医药产业集群中的风险投资优势  

Analysis about the comparative advantage of venture capital in medicine industrial clusters

作　　者：卢春丽[1] 曹阳[1] 

机构地区：[1]中国药科大学国际医药商学院,江苏南京210009

出　　处：《中国医药技术经济与管理》2008年第12期68-72,共5页China Pharmaceutical Technology Economics & Management

摘　　要：目的探讨我国医药产业集群吸收风险投资的优势。方法运用规范和实证研究方法。结果论述医药行业中风险投资现状、医药产业集群在吸引风险投资方面的优势,并对医药产业集群吸引风险投资进行了建议和展望。结论应该充分发挥医药产业集群化发展在吸引风险投资方面的优势,获得更多的风险资金支持。Objective To discuss the advantage of the medicine industry cluster in absorbing venture capital （VC）. Methods Using the normative and positive economic methods. Results Discussing the current situation of the VC in the medicine industry, and the advantage of medicine industrial cluster in VC absorption, and making some proposition and giving a prospect of the medicine industrial clusters in VC absorption. Conclusion We should make full use of the advantage of the medicine industrial clusters in VC absorption, to gain more financial support.

关 键 词：风险投资 医药产业集群 优势 

分 类 号：R977[医药卫生—药品] R95[医药卫生—药学]